F&S science · 2026
Molecular and Developmental Integrity Following Trophectoderm Biopsy: Evidence from Human and Mouse Models.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
McCallie Blair R, Denomme Michelle M, Bochantin-Winders Kerri A, Haywood Mary E, Wilson Jason R, McCarty Keelee J, Hebert Cameron M, Hamm Jennifer M, Schoolcraft William B, Katz-Jaffe Mandy G
Аннотация
OBJECTIVE: To determine whether trophectoderm (TE) biopsy performed for preimplantation genetic testing induces molecular, epigenetic, or developmental perturbations in preimplantation embryos and subsequent placental development.
DESIGN: Comparative multi-omics investigation of human blastocysts combined with a murine embryo transfer model.
SUBJECTS: Surplus cryopreserved human euploid blastocysts donated to research and murine blastocysts that were either subjected to TE biopsy or no biopsy.
EXPOSURE: The impact of blastocyst-stage trophectoderm biopsy on transcriptomic, epigenomic, developmental, and/or placental outcomes.
MAIN OUTCOME MEASURES: Differential gene expression, imprinting methylation, whole-genome DNA methylation of inner cell mass (ICM) and TE, mitotic cell division mechanics, implantation rates, fetal and placental growth, placental methylation.
RESULTS: Trophectoderm biopsy was not associated with biologically meaningful molecular or epigenetic alterations in human blastocysts. Gene expression, imprinting methylation, global DNA methylation, and DNA budding/shedding were comparable between biopsied and non-biopsied embryos. In a murine model, biopsy had no effect on implantation rates, fetal or placental growth, placental methylome, or imprinting methylation status.
CONCLUSION: A comprehensive multi-omics assessment of human blastocysts, supported by developmental and placental analyses in a murine model, found no evidence that trophectoderm biopsy adversely affects early embryonic molecular regulation or subsequent developmental outcomes. These findings support the use of TE biopsy as a minimally invasive micro-manipulation procedure.
DESIGN: Comparative multi-omics investigation of human blastocysts combined with a murine embryo transfer model.
SUBJECTS: Surplus cryopreserved human euploid blastocysts donated to research and murine blastocysts that were either subjected to TE biopsy or no biopsy.
EXPOSURE: The impact of blastocyst-stage trophectoderm biopsy on transcriptomic, epigenomic, developmental, and/or placental outcomes.
MAIN OUTCOME MEASURES: Differential gene expression, imprinting methylation, whole-genome DNA methylation of inner cell mass (ICM) and TE, mitotic cell division mechanics, implantation rates, fetal and placental growth, placental methylation.
RESULTS: Trophectoderm biopsy was not associated with biologically meaningful molecular or epigenetic alterations in human blastocysts. Gene expression, imprinting methylation, global DNA methylation, and DNA budding/shedding were comparable between biopsied and non-biopsied embryos. In a murine model, biopsy had no effect on implantation rates, fetal or placental growth, placental methylome, or imprinting methylation status.
CONCLUSION: A comprehensive multi-omics assessment of human blastocysts, supported by developmental and placental analyses in a murine model, found no evidence that trophectoderm biopsy adversely affects early embryonic molecular regulation or subsequent developmental outcomes. These findings support the use of TE biopsy as a minimally invasive micro-manipulation procedure.